Healthcare has always been a space where the money follows the obvious. Build hospitals, fund pharma, scale diagnostics—these are the classic plays that investors have poured billions into. But while capital has been flowing into physical infrastructure and cutting-edge technology, there is one part of the healthcare system that has been completely overlooked, despite the fact that it determines whether patients even get access to treatment in the first place. The real bottleneck in Indian healthcare isn’t the availability of doctors or medical facilities, it’s something far simpler and far more powerful: money.
India has one of the highest out-of-pocket healthcare expenditures in the world, with over fifty percent of medical costs being paid directly by patients, compared to just eleven percent in the US and thirty percent in China. This isn’t a minor inconvenience. This is the difference between a child getting early intervention for a serious illness or a family waiting until it’s too late. This is the reason why millions of Indians either delay or entirely skip medical treatment. It’s not about whether the hospital exists; it’s about whether the patient can afford to walk through the door.
The numbers tell the story better than anything else. Over sixty percent of hospital expenses in India are financed by personal savings or high-interest informal loans, pushing millions of families into debt every year. The entire healthcare sector has been built on the assumption that people will find a way to pay. But what happens when they can’t? The traditional healthcare investment narrative has focused on where the next big hospital chain will expand, but the real question is why the beds in those hospitals remain empty for people who need them the most.
Private equity has spent years searching for the next scalable healthcare investment, yet somehow it has ignored the fact that healthcare financing itself is the market waiting to explode. Health insurance penetration in India remains low, especially outside major cities, and while the government has introduced programs to improve coverage, the reality is that a vast majority of Indians still pay for healthcare on their own. This is where an entirely new investment playbook is being written. Subscription-based healthcare plans, EMI-driven medical financing, micro-insurance models—these aren’t just stopgap solutions, they are becoming the new infrastructure of Indian healthcare.
A wave of fintech-healthcare startups is already proving that affordability is the real unlock. Companies are offering zero-interest installment plans for hospital bills, allowing patients to break payments into manageable monthly chunks. Others are building models where preventive healthcare is bundled into low-cost subscription packages, shifting healthcare spending from reactive to proactive. The smartest investors are starting to realize that access to capital is just as critical as access to doctors.
Indian hospitals have focused on expansion, thinking that more beds and more facilities will solve the problem. But the next frontier isn’t just about building more, it’s about ensuring that the people who need healthcare can actually afford to use it. Private capital is already reshaping Indian healthcare, but the biggest opportunity isn’t in the operating rooms, it’s in the financial products that will determine who gets to walk in. The future of Indian healthcare won’t be dictated by how many hospitals are built, but by how many people are given a way to afford the care they need. The investors who understand this first will be the ones who win.
Sources: EY Report: “The AIdea of India 2025 – How Much Productivity Can GenAI Unlock in India
TERMS OF USE
Thank you for your interest in our Website at https://unlistedintel.com/. Your use of this Website, including the content, materials and information available on or through this Website (together, the “Materials”), is governed by these Terms of Use (these “Terms”). By using this Website, you acknowledge that you have read and agree to these Terms.
NO OFFER, SOLICITATION OR ADVICE
Our site is provided for informational purposes only. It does not constitute to constitute (i) an offer, or solicitation of an offer, to
purchase or sell any security, other assets, or service, (ii) investment, legal, business, or tax advice, or an offer to provide such advice or (iii) a basis for making any investment decision.
The Materials are provided for informational purposes and have been prepared by Oister Global for informational purposes to acquaint existing and prospective underlying funds, entrepreneurs, and other company founders with Oister Global's recent and historical investment activities.
Please note that any investments or portfolio companies referenced in the Materials are illustrative and do not reflect the performance of any Oister Global fund as a whole. There is no obligation for Oister Global to update or alter any forward-looking statements, whether as a result of new information, future events, or otherwise.
PURPOSE LIMITATION AND ACCESS TO YOUR PERSONAL DATA:
We will only collect your personal data in a fair, lawful, and transparent manner. We will keep your personal data accurate and up to date. We will process your personal data in line with your legal rights. We use your name and contact details, such as email, postal address, and contact number to continue communications with you. We may also use your contact information to invite you to events we are hosting or to keep you updated with our news.
USE OF COOKIES OR SIMILAR DEVICES
We use cookies on our website. This helps us to provide you with a better experience when you browse our website and also allows us to make improvements to our site. You may be able to change the preferences on your browser or device to prevent or limit your device’s acceptance of cookies, but this may prevent you from taking advantage of some of our features.
MATERIAL
The material displayed on our site is provided “as is”, without any guarantees, conditions, or warranties as to its accuracy, completeness, or reliability. You should be aware that a significant portion of the Materials includes or consists of information that has been provided by third parties and has not been validated or verified by us. In connection with our investment activities, we often become subject to a variety of confidentiality obligations to funds, investors, portfolio companies, and other third parties. Any statements we make may be affected by those confidentiality obligations, with the result that we may be prohibited from making full disclosures.
MISCELLANEOUS
This Website is operated and controlled by Oister Global in India. We may change the content on our site at any time. If the need arises, we may suspend access to our site, or close it indefinitely. We are under no obligation to update any material on our site.
CONTACT INFORMATION
Any questions, concerns or complaints regarding these Terms should be sent to info@oisterglobal.com